跳至主要内容
临床试验/JPRN-UMIN000024275
JPRN-UMIN000024275已完成未知

Therapeutic efficacy of magnesium oxide for peripheral artery disease among patients undergoing hemodialysis - Open label randomized controlled trial - Therapeutic efficacy of magnesium oxide for peripheral artery disease

Department of Comprehensive Kidney Disease Research, Osaka University Graduate School of Medicine0 个研究点目标入组 90 人开始时间: 2016年12月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with serum magnesium levels of 3.4 mg/dL or greater. 2. Patients who had experienced side effects by magnesium oxide or rebamipide. 3. Patients currently taking magnesium oxide. 4. Patients suffering from critical limb ischemia. 5. Patients currently taking part in other interventional studies.

研究者

发起方
Department of Comprehensive Kidney Disease Research, Osaka University Graduate School of Medicine

相似试验